Growth inhibition mediated via p53-dependent [33,34,48] and p53-independent [16,49,50] mechanisms have been reported with non-selective and selective COX-2 inhibitors in studies of tumour and non-tumour cells. The gene discussed is TP53; the disease is neoplasm.